Intrinsic Value of S&P & Nasdaq Contact Us

IRadimed Corporation IRMD NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
79/100
5/7 Pass
SharesGrow Intrinsic Value
$64.16
-31.4%
Analyst Price Target
$120.00
+28.3%

Stock Statistics — IRMD

IRadimed Corporation (IRMD) has a market capitalization of $1.2B and trades at $93.56. The 52-week range is 47.478-107.9.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 52.9, Earnings Per Share (EPS) of $1.77, annual revenue of $83.81M.

The stock has a beta of 1.12, a last dividend of $1.2100, operates in the Healthcare sector.

Trading Data
Current Price$93.56
52-Week Range47.478-107.9
Volume77.6K
Avg Volume (30D)78.76K
Market Cap$1.2B
Beta (1Y)1.12
Last Dividend$1.2100
Company
IPO Date2014-07-16
Employees160
CEORoger E. Susi
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS46266A1097
CUSIP46266A109
Income (Latest Year)
Revenue$83.81M
Gross Profit$64.32M
EBITDA$28.53M
Operating Income$26.15M
Net Income$22.48M
EPS$1.77
EPS Diluted$1.75
Shares Outstanding$12.72M
Balance Sheet (Latest Year)
Total Assets$108.78M
Current Assets$81.2M
Cash & ST Investments$51.16M
Total Liabilities$14.16M
Net Debt$-51.16M
Total Equity$94.62M
Valuation Ratios
P/E Ratio52.9
P/S Ratio14.27
P/B Ratio12.64
EV/EBITDA (approx)41.9
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message